Z
Zisheng Chen
Researcher at Guangzhou Medical University
Publications - 15
Citations - 2028
Zisheng Chen is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 5, co-authored 11 publications receiving 876 citations.
Papers
More filters
Journal ArticleDOI
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.
Wenhua Liang,Hengrui Liang,Limin Ou,Binfeng Chen,Ailan Chen,Caichen Li,Yimin Li,Wei-jie Guan,Ling Sang,Jiatao Lu,Yuanda Xu,Yuanda Xu,Guoqiang Chen,Haiyan Guo,Jun Guo,Zisheng Chen,Yi Zhao,Shiyue Li,Nuofu Zhang,Nanshan Zhong,Jianxing He +20 more
TL;DR: A risk score based on characteristics of COVID-19 patients at the time of admission to the hospital was developed that may help predict a patient's risk of developing critical illness.
Posted ContentDOI
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
Wei-jie Guan,Wenhua Liang,Yi Zhao,Hengrui Liang,Zisheng Chen,Yimin Li,Xiaoqing Liu,Ruchong Chen,Chun-Li Tang,Tao Wang,Chun-Quan Ou,Li Li,Ping-Yan Chen,Ling Sang,Wei Wang,Jianfu Li,Caichen Li,Limin Ou,Bo Cheng,Shan Xiong,Zhengyi Ni,Jie Xiang,Yu Hu,Lei Liu,Hong Shan,Chunliang Lei,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Linling Cheng,Feng Ye,Shiyue Li,Jinping Zheng,Nuofu Zhang,Nanshan Zhong,Jianxing He +46 more
TL;DR: Comorbidities are present in around one fourth of patients with COVID-19 in China, and predispose to poorer clinical outcomes, and have significantly escalated risks of reaching to the composite endpoint compared with those who had a single comorbidity.
Journal ArticleDOI
Early triage of critically ill COVID-19 patients using deep learning
Wenhua Liang,Jianhua Yao,Ailan Chen,Qingquan Lv,Mark Zanin,Jun Liu,Sook San Wong,Yimin Li,Jiatao Lu,Hengrui Liang,Guoqiang Chen,Haiyan Guo,Jun Guo,Rong Zhou,Limin Ou,Zhou Niyun,Hanbo Chen,Fan Yang,Xiao Han,Wenjing Huan,Weimin Tang,Wei-jie Guan,Zisheng Chen,Yi Zhao,Ling Sang,Yuanda Xu,Wei Wang,Shiyue Li,Ligong Lu,Nuofu Zhang,Nanshan Zhong,Junzhou Huang,Jianxing He +32 more
TL;DR: A deep learning-based survival model can predict the risk of COVID-19 patients developing critical illness based on clinical characteristics at admission and is used to create an online calculation tool designed for patient triage at admission to identify patients at risk of severe illness.
Journal ArticleDOI
An annual review of the remarkable advances in lung cancer clinical research in 2019.
Bo Cheng,Shan Xiong,Caichen Li,Hengrui Liang,Yi Zhao,Jianfu Li,Jiang Shi,Limin Ou,Zisheng Chen,Peng Liang,Wenhua Liang,Jianxing He +11 more
TL;DR: In summary, survival among lung cancer patients was significantly improved compared with historical controls, turning lung cancer from an incurable disease into a chronic disease.
Journal ArticleDOI
Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung cancer: A systematic review and network meta-analysis.
Yi Zhao,Bo Cheng,Zisheng Chen,Jianfu Li,Hengrui Liang,Ying Chen,Feng Zhu,Caichen Li,Ke Xu,Shan Xiong,Weixiang Lu,Zhuxing Chen,Ran Zhong,Shen Zhao,Zhanhong Xie,Jun Liu,Wenhua Liang,Jianxing He +17 more
TL;DR: In this paper, the toxicity profile including toxicity incidence, severity, and spectrum (involving various specific adverse events) of each EGFR-TKI are of particular clinical interest and importance.